A generic solution? Pharmaceuticals and the politics of the similar in Mexico
A generic solution? Pharmaceuticals and the politics of the similar in Mexico
复制标题
DOI：
10.1086/518301
复制
发表时间：
2007-08-01
影响因子：
2.2
通讯作者：
Hayden, Cori
中科院分区：
文献类型：
--
作者：
Hayden, Cori
1997年和1998年，墨西哥政府鼓励将仿制药引入墨西哥，墨西哥是拉丁美洲最大和增长最快的制药市场。在巴西，抗逆转录病毒药物和艾滋病毒/艾滋病治疗一直是国家领导的强有力的仿制药“革命”的核心，与此相反，在墨西哥，转向更便宜的仿制药在私营部门取得了最大的成绩。快速增长的制药连锁企业Farmacias Similares，其民粹主义民族主义（“墨西哥产品帮助那些拥有最少的人”）、附属实验室、政治运动、健康诊所和座右铭--“一样但更便宜”--已经开始改变该国医疗保健提供的面貌，这就提出了一个重要的问题，即仿制药市场的出现是否实际上标志着墨西哥公共卫生中“公众”的重新主张。被复制的药物如何配置一套特定的政治实践和话语，以（墨西哥）公共利益的名义发起？
In 1997 and 1998 the Mexican government encouraged the introduction of generic drugs into Mexico, Latin America's biggest and fastest-growing pharmaceutical market. In contrast to the situation in Brazil, where anti-retrovirals and HIV/AIDS treatment have been the centerpiece of a powerful state-led generics "revolution," in Mexico the move to cheaper, copied medicines has made its strongest mark in the private sector. The rapidly growing pharmaceutical chain Farmacias Similares, whose populist nationalism ("Mexican Products to Help Those Who Have the Least"), affiliated laboratories, political movements, health clinics, and motto - "The Same But Cheaper" - have begun to transform the face of health care provision in that country, raises important questions about whether the emergence of a market for generic medicines does in fact signal the reassertion of "the public" in and for Mexican public health. How does the copied pharmaceutical configure a particular set of political practices and discourses launched in the name of the (Mexican) public interest?